Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs SAROJA PHARMA INDUSTRIES INDIA LTD. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA SAROJA PHARMA INDUSTRIES INDIA LTD. CIPLA/
SAROJA PHARMA INDUSTRIES INDIA LTD.
 
P/E (TTM) x 26.6 - - View Chart
P/BV x 4.5 1.6 281.5% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 CIPLA   SAROJA PHARMA INDUSTRIES INDIA LTD.
EQUITY SHARE DATA
    CIPLA
Mar-24
SAROJA PHARMA INDUSTRIES INDIA LTD.
Mar-24
CIPLA/
SAROJA PHARMA INDUSTRIES INDIA LTD.
5-Yr Chart
Click to enlarge
High Rs1,51983 1,832.3%   
Low Rs88635 2,530.4%   
Sales per share (Unadj.) Rs319.3101.2 315.6%  
Earnings per share (Unadj.) Rs51.52.2 2,357.1%  
Cash flow per share (Unadj.) Rs64.52.4 2,665.0%  
Dividends per share (Unadj.) Rs13.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs329.836.4 905.5%  
Shares outstanding (eoy) m807.154.02 20,078.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.80.6 646.1%   
Avg P/E ratio x23.427.0 86.5%  
P/CF ratio (eoy) x18.624.4 76.5%  
Price / Book Value ratio x3.61.6 225.2%  
Dividend payout %25.30-   
Avg Mkt Cap Rs m970,457237 409,462.7%   
No. of employees `000NANA-   
Total wages/salary Rs m43,1009 466,959.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m257,741407 63,375.3%  
Other income Rs m7,4662 380,903.1%   
Total revenues Rs m265,207409 64,898.2%   
Gross profit Rs m60,96226 238,506.7%  
Depreciation Rs m10,5101 1,106,336.8%   
Interest Rs m89915 6,198.6%   
Profit before tax Rs m57,01912 472,402.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,4663 470,088.1%   
Profit after tax Rs m41,5539 473,269.9%  
Gross profit margin %23.76.3 376.4%  
Effective tax rate %27.127.2 99.6%   
Net profit margin %16.12.2 746.5%  
BALANCE SHEET DATA
Current assets Rs m193,925176 110,196.9%   
Current liabilities Rs m52,45893 56,454.7%   
Net working cap to sales %54.920.4 268.7%  
Current ratio x3.71.9 195.2%  
Inventory Days Days953 3,259.2%  
Debtors Days Days71,458 0.5%  
Net fixed assets Rs m126,88690 141,535.0%   
Share capital Rs m1,61540 4,015.7%   
"Free" reserves Rs m264,584106 249,114.2%   
Net worth Rs m266,199146 181,805.0%   
Long term debt Rs m026 0.0%   
Total assets Rs m321,300266 120,962.4%  
Interest coverage x64.41.8 3,516.6%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.81.5 52.4%   
Return on assets %13.28.8 150.7%  
Return on equity %15.66.0 260.2%  
Return on capital %21.815.4 141.4%  
Exports to sales %22.20-   
Imports to sales %9.20-   
Exports (fob) Rs m57,150NA-   
Imports (cif) Rs m23,657NA-   
Fx inflow Rs m74,80070 106,113.6%   
Fx outflow Rs m23,6570 5,257,000.0%   
Net fx Rs m51,14370 73,019.7%   
CASH FLOW
From Operations Rs m41,33910 403,308.3%  
From Investments Rs m-29,880-48 62,747.4%  
From Financial Activity Rs m-12,00437 -32,488.0%  
Net Cashflow Rs m-4900 116,642.9%  

Share Holding

Indian Promoters % 10.9 73.0 14.9%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 52.9 0.0 -  
FIIs % 28.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 69.1 27.0 256.0%  
Shareholders   470,234 438 107,359.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs SAROJA PHARMA INDUSTRIES INDIA LTD.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs SAROJA PHARMA INDUSTRIES INDIA LTD. Share Price Performance

Period Cipla SAROJA PHARMA INDUSTRIES INDIA LTD. S&P BSE HEALTHCARE
1-Day 0.75% 0.00% 0.58%
1-Month -2.29% 3.48% -0.89%
1-Year 16.12% 2.75% 42.69%
3-Year CAGR 18.17% -5.31% 20.09%
5-Year CAGR 25.28% -3.22% 26.08%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the SAROJA PHARMA INDUSTRIES INDIA LTD. share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 30.9% stake in the company. In case of SAROJA PHARMA INDUSTRIES INDIA LTD. the stake stands at 73.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of SAROJA PHARMA INDUSTRIES INDIA LTD..

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 13.0 per share. This amounted to a Dividend Payout ratio of 25.3%.

SAROJA PHARMA INDUSTRIES INDIA LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Cipla, and the dividend history of SAROJA PHARMA INDUSTRIES INDIA LTD..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.